Program Manager - R&D Consortium
(Israel Innovation Authority, Track 5)
CytoReason, together with TeraCyte and leading partners from industry and academia including Weizmann Institute, Technion, Ben-Gurion University, Sheba Medical Center, Teva, and NVIDIA, are establishing a new R&D consortium supported by the Israel Innovation Authority (Track 5).
The consortium focuses on developing tools and infrastructure for creating multimodal datasets used to train AI models of biological systems, advancing collaborative pre-competitive research and strengthening Israel’s leadership in life sciences and artificial intelligence.
We are seeking a Program Manager to lead the operational and strategic coordination of the consortium, manage the relationship with the Israel Innovation Authority, and facilitate collaboration across partners.
The role includes working closely with senior executives and research leaders across industry and academia, ensuring effective collaboration, promoting technological excellence, and maximizing the impact of the consortium.
Position details :
Consortium Coordination and Operations
Strategic Development and Collaboration
Governance and Interface with the Israel Innovation Authority
Monitoring and Reporting
None

CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases – tissue by tissue and cell by cell. Researchers of all levels rely on CytoReason’s technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain valuable tools to manage and optimize entire drug portfolios.